{
    "2020-08-28": [
        [
            {
                "time": "",
                "original_text": "乐普医疗中报点评：Q2业绩大幅改善，创新器械步入收获期【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "Q2",
                        "业绩改善",
                        "创新器械",
                        "收获期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【天风医药】乐普医疗：心血管器械龙头不忘初心，二季度业绩恢复明显，看好全年发展",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "心血管器械",
                        "龙头",
                        "二季业绩恢复",
                        "全年发展"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "兴业证券：关注政策变化 重点配置消费医疗+创新板块",
                "features": {
                    "keywords": [
                        "兴业证券",
                        "政策变化",
                        "消费医疗",
                        "创新板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "创新"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "迈瑞医疗大涨超4%，提振医疗保健板块",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "大涨",
                        "医疗保健板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药】二季度业绩明显回暖，创新研发持续加码——乐普医疗（300003）2020年半年报点评——增持",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "二季度",
                        "业绩回暖",
                        "创新研发",
                        "增持"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗(300003)：二季度公司业绩逐渐回暖",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "二季度",
                        "业绩回暖"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}